Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Centenaire Bioscience

Explore full profile

Exploring deep disease space to find cures for incurable conditions

South Korea
Valuation $100–250M Last recorded · 2023
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Centenaire Bioscience and the history behind them.

About Centenaire Bioscience

Centenaire Biosciences is dedicated to discovering cures for diseases deemed incurable, operating within the pharmaceutical and biotechnology sectors. The company focuses on deep disease exploration, aiming to bring new hope to patients in the homo hundred era. With a business model centered around research and development, Centenaire Biosciences generates revenue through strategic partnerships and investments, such as their recent Series A funding. The company serves a global market, targeting healthcare providers and patients in need of advanced therapeutic solutions. Led by experienced professionals like Deokjae Lee, who has a background in biologics and small molecule pharmaceuticals, Centenaire Biosciences is positioned to make significant contributions to the field of disease treatment.

Source: Dealroom company data

At a glance

Status
Operational
Headquarters
South Korea
Open positions
None listed
Dealroom signal
0.0/100
Business model
Manufacturing
Links
Website

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Feb 2023 $18M $70M Undisclosed ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Centenaire Bioscience website traffic

Latest recorded traffic for Centenaire Bioscience is 3.3K monthly website visits, up 32% over the last three months.

Latest monthly visits3.3K 3-month web change+32%
Monthly website visitsSep 2025–May 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇰🇷 South Korea HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Centenaire Bioscience on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Centenaire Bioscience’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.